Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp Cmn (TECH) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,693,690
  • Shares Outstanding, K 37,300
  • Annual Sales, $ 499,020 K
  • Annual Income, $ 104,480 K
  • 36-Month Beta 0.71
  • Price/Sales 7.40
  • Price/Book 4.12

Price Performance

See More
Period Period Low Period High Performance
1-Month
97.61 +0.42%
on 01/19/17
106.03 -7.55%
on 01/04/17
-6.69 (-6.39%)
since 12/20/16
3-Month
97.61 +0.42%
on 01/19/17
109.36 -10.37%
on 12/09/16
-7.92 (-7.48%)
since 10/20/16
52-Week
80.46 +21.82%
on 01/28/16
117.42 -16.52%
on 07/08/16
+15.63 (+18.97%)
since 01/20/16

Most Recent Stories

More News
Bio-Techne And Astute Medical Form Strategic Partnership

Bio-Techne Corporation (NASDAQ: TECH) today closed on a strategic equity investment in Astute Medical, Inc. (San Diego, CA), a diagnostic company devoted to improving patient healthcare outcomes through...

ProteinSimple's Single-Cell Western platform named #1 on The Scientist's Top 10 Innovations of 2016

For nine years running, The Scientist has sought out recently released laboratory and research products that are making waves in life science laboratories. And for nine years, their expert panels of independent...

Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2016. The quarterly dividend will be payable...

Bio-Techne Releases First Quarter Fiscal 2017 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2016.

Bio-Techne To Host Conference Call On October 31, 2016 To Announce First Quarter Financial Results

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Monday, October 31, 2016, at 8:00 a.m. CDT to review first quarter fiscal 2017 financial results.

Bio-Techne Announces Investor Day And Webcast

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte...

Bio-Techne Announces Investor Day And Webcast

Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte...

RSI Alert: Bio-Techne (TECH) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended June 30, 2016. The quarterly dividend will be payable...

Medical Stocks' Earnings to Watch Next Week: TECH, WVE, EARS

How will medical stocks Bio-Techne, WAVE Life Sciences, and Auris perform this earnings season?

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Support & Resistance

2nd Resistance Point 99.17
1st Resistance Point 98.60
Last Price 98.02
1st Support Level 97.60
2nd Support Level 97.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.